Sunday, November 22nd, 2009

Posts Tagged ‘ Antisense Drugs ’

It’s time to buy Isis Pharmaceuticals (ISIS)

Dec 19th, 2008 | By Laura Cadden | Category: Financial News

Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) is a biopharmaceutical company that focuses entirely on RNA-based technologies and primarily, on antisense therapies.